Adverum Biotechnologies

Developer of gene therapy based therapies for wet age-related macular degeneration & ophthalmologic disorders

placeMenlo Park, California, United States calendar_todayFounded 2006 groups123 employees language adverum.com

Registered entities

Innovation

36 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 6,300 times.

YearFilings
20151
20163
20177
201811
201910
202011
202115
202216
202314
202417
202517
202613

Social engagement

Social engagement: 15.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Venrock; 1 has since exited.

Investor typeCountShare
Venture capital956%
Private equity16%
Bank & private debt319%
Other / undisclosed319%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

8 Apr 2026 · Sample Logistics Coordinator, Lab Operations (Contract) · Redwood City

Based on job postings tracked across public sources.

Recent activity

16 Oct 2025
Event
Eyecelerator at American Academy of Ophthalmology Annual Meeting
24 Sep 2025
Recognition
22 Sep 2025
Milestone
regulatory
Coming soon